{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:10:13Z","timestamp":1790982613349,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.eururo.2014.09.007","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T15:48:27Z","timestamp":1411487307000},"page":"241-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":260,"title":["Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"67","author":[{"given":"Homayoun","family":"Zargar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N.","family":"Espiritu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian S.","family":"Fairey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin P.","family":"Dinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Maria","family":"Krabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels-Erik","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay M.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan Y.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Campain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Kassouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Dall\u2019Era","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-An","family":"Seah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar E.","family":"Ercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Horenblas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikala S.","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Aning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Holzbeierlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinity J.","family":"Bivalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Barocas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas W.","family":"van Rhijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Daneshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.09.007_bib0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"Stenzl","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2014.09.007_bib0015","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(03)13580-5","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2014.09.007_bib0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data","volume":"48","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0025","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"Griffiths","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2014.01.014","article-title":"The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study","volume":"66","author":"Gandaglia","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bju.12585","article-title":"Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity","volume":"114","author":"Johnson","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2014.09.007_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.urology.2013.07.072","article-title":"Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database","volume":"83","author":"Zaid","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.09.007_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.eururo.2012.11.015","article-title":"Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base","volume":"63","author":"Gray","year":"2013","journal-title":"Eur Urol"},{"issue":"Suppl 2","key":"10.1016\/j.eururo.2014.09.007_bib0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bju.12384","article-title":"USANZ: time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer","volume":"112","author":"Liew","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2014.09.007_bib0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.eururo.2014.01.009","article-title":"Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides","volume":"67","author":"Reardon","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0060","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2009.03.021","article-title":"Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer","volume":"29","author":"Porter","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0070","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.urolonc.2012.07.005","article-title":"Neoadjuvant chemotherapy with gemcitabine\/cisplatin vs. methotrexate\/vinblastine\/doxorubicin\/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California","volume":"31","author":"Fairey","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0075","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/cncr.23848","article-title":"A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience","volume":"113","author":"Dash","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.09.007_bib0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clgc.2012.08.004","article-title":"Retrospective analysis of clinical outcomes with neoadjuvant cisplatin-based regimens for muscle-invasive bladder cancer","volume":"10","author":"Pal","year":"2012","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2014.09.007_bib0085","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.urology.2011.10.050","article-title":"Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder","volume":"79","author":"Yeshchina","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.09.007_bib0090","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/cncr.24466","article-title":"Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy","volume":"115","author":"Sonpavde","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.09.007_bib0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2013.06.049","article-title":"Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis","volume":"65","author":"Petrelli","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0100","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.eururo.2011.12.010","article-title":"Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer","volume":"61","author":"Rosenblatt","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0105","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/annonc\/mdu126","volume":"25","author":"Kitamura","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/030089169608200511","article-title":"Neoadjuvant CMV chemotherapy plus radical cystectomy in locally advanced bladder cancer: the impact of pathologic response on long-term results","volume":"82","author":"Scattoni","year":"1996","journal-title":"Tumori"},{"key":"10.1016\/j.eururo.2014.09.007_bib0115","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.1994.12.5.975","article-title":"Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer","volume":"12","author":"Herr","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/jjco\/hyr068","article-title":"Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer","volume":"41","author":"Kaneko","year":"2011","journal-title":"Jpn J Cin Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejso.2013.01.003","article-title":"Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience","volume":"39","author":"Meijer","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cncr.24106","article-title":"Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series","volume":"115","author":"Weight","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.09.007_bib0135","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.juro.2012.10.120","article-title":"Pooled analysis of clinical outcomes with neoadjuvant cisplatin and gemcitabine chemotherapy for muscle invasive bladder cancer","volume":"189","author":"Yuh","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0140","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1590\/S1677-55382007000500004","article-title":"Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma","volume":"33","author":"Herchenhorn","year":"2007","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.juro.2013.07.006","article-title":"Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum\/gemcitabine combination chemotherapy","volume":"191","author":"North","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0150","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2013.11.046","article-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines","volume":"65","author":"Witjes","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0155","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1966::AID-CNCR14>3.0.CO;2-W","article-title":"Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma","volume":"80","author":"Bellmunt","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.09.007_bib0160","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.juro.2008.08.075","article-title":"Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder","volume":"180","author":"Smith","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0165","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.juro.2009.01.115","article-title":"A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219)","volume":"181","author":"deVere White","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.urology.2013.03.044","article-title":"A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder","volume":"82","author":"Grivas","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.09.007_bib0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jjco\/hys213","article-title":"Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer","volume":"43","author":"Iwasaki","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.eururo.2013.06.002","article-title":"Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?","volume":"64","author":"Niegisch","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.09.007_bib0180","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.juro.2012.06.018","article-title":"Carboplatin based induction chemotherapy for nonorgan confined bladder cancer\u2014a reasonable alternative for cisplatin unfit patients?","volume":"188","author":"Mertens","year":"2012","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814008938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814008938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T08:50:50Z","timestamp":1565859050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814008938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0302283814008938"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.09.007","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}